speb/financial-data huggingface dataset:
ELAB balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
ELAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
ELAB income_statement (annual, 2024-12-31) — Normalized EBITDA: -3631879.00
ELAB income_statement (annual, 2024-12-31) — Normalized Income: -4380026.00
ELAB cash_flow (annual, 2024-12-31) — Operating Cash Flow: -5486980.00
ELAB cash_flow (annual, 2024-12-31) — Operating Gains Losses: -369158.00
ELAB income_statement (annual, 2024-12-31) — Operating Income: -3657720.00
ELAB income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 5226.00
ELAB balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 548916.00
ELAB balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 548916.00
ELAB balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -337.00
ELAB balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -337.00
ELAB income_statement (annual, 2024-12-31) — Other Gand A: 2858091.00
ELAB income_statement (annual, 2024-12-31) — Other Income Expense: 363312.00
ELAB balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2801993.00
ELAB cash_flow (annual, 2024-12-31) — Other Non Cash Items: 766132.00
ELAB income_statement (annual, 2024-12-31) — Other Operating Expenses: 236907.00
ELAB balance_sheet (annual, 2024-12-31) — Other Payable: 350000.00
ELAB balance_sheet (quarterly, 2024-12-31) — Other Payable: 350000.00
ELAB balance_sheet (annual, 2024-12-31) — Other Receivables: 5276.00
ELAB balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Payables: 1250218.00
ELAB balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1250218.00
ELAB balance_sheet (annual, 2024-12-31) — Prepaid Assets: 868464.00
ELAB income_statement (annual, 2024-12-31) — Pretax Income: -4016714.00
ELAB cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Properties: 0.00
ELAB balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ELAB cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 0.00
ELAB cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
ELAB cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -462320.00
ELAB cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -300000.00
ELAB cash_flow (annual, 2024-12-31) — Purchase Of Investment: -139084.00
ELAB cash_flow (annual, 2024-12-31) — Purchase Of PPE: -9160.00
ELAB cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Receivables: 5276.00
ELAB income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
ELAB income_statement (annual, 2024-12-31) — Reconciled Depreciation: 12950.00
ELAB cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1150000.00
ELAB cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
ELAB cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
ELAB income_statement (annual, 2024-12-31) — Research And Development: 104654.00
ELAB balance_sheet (annual, 2024-12-31) — Retained Earnings: -13269627.00
ELAB income_statement (annual, 2024-12-31) — Salaries And Wages: 165000.00
ELAB cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
ELAB income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 292522.00
ELAB income_statement (annual, 2024-12-31) — Selling General And Administration: 3315613.00
ELAB balance_sheet (annual, 2024-12-31) — Share Issued: 5226.00
ELAB income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
ELAB cash_flow (annual, 2024-12-31) — Stock Based Compensation: 97167.00
ELAB balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6659564.00
ELAB balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3857571.00
ELAB income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ELAB income_statement (annual, 2024-12-31) — Tax Provision: 0.00
ELAB income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Taxes Receivable: 5276.00
ELAB balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 5276.00
ELAB balance_sheet (annual, 2024-12-31) — Total Assets: 8993165.00
ELAB balance_sheet (annual, 2024-12-31) — Total Capitalization: 6659564.00
ELAB balance_sheet (annual, 2024-12-31) — Total Debt: 0.00
ELAB balance_sheet (quarterly, 2024-12-31) — Total Debt: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 6659564.00
ELAB income_statement (annual, 2024-12-31) — Total Expenses: 3657720.00
ELAB balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2333601.00
ELAB balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2942164.00
ELAB balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 534467.00
ELAB income_statement (annual, 2024-12-31) — Total Unusual Items: 363312.00
ELAB income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 363312.00
ELAB balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 534467.00
ELAB balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 534467.00
ELAB balance_sheet (annual, 2024-12-31) — Trading Securities: 139084.00
ELAB balance_sheet (quarterly, 2024-12-31) — Trading Securities: 139084.00
ELAB cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ELAB balance_sheet (annual, 2024-12-31) — Working Capital: 4251867.00
ELAB income_statement (annual, 2024-12-31) — Write Off: 0.00
ELAB income_statement (quarterly, 2025-03-31) — +Operating Expense: 1201338.00
ELAB income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 384418.00
ELAB balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2604.00
ELAB balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 23006702.00
ELAB balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Basic Average Shares: 6485.00
ELAB income_statement (quarterly, 2025-03-31) — Basic EPS: -248.03
ELAB cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3984453.00
ELAB balance_sheet (quarterly, 2025-03-31) — Capital Stock: 708.00
ELAB balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5364434.00
ELAB balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5921809.00
ELAB balance_sheet (quarterly, 2025-03-31) — Cash Financial: 5364434.00
ELAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2943185.00
ELAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -215319.00
ELAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1347416.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 259661.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Inventory: 22966.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -20496.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Payable: -138067.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -138067.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 69575.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Receivables: -76660.00
ELAB cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -142682.00
ELAB cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1380450.00
ELAB balance_sheet (quarterly, 2025-03-31) — Common Stock: 71.00
ELAB balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 8127875.00
ELAB cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 1484028.00
ELAB cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -179.00
ELAB income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Current Assets: 6816148.00
ELAB balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 760268.00
ELAB cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1601.00
ELAB income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 1085.00
ELAB cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1601.00
ELAB income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1085.00
ELAB income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 6485.00
ELAB income_statement (quarterly, 2025-03-31) — Diluted EPS: -248.03
ELAB income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1608455.00
ELAB balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 375850.00
ELAB income_statement (quarterly, 2025-03-31) — EBIT: -1570337.00
ELAB income_statement (quarterly, 2025-03-31) — EBITDA: -1568736.00
ELAB cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -469.00
ELAB cash_flow (quarterly, 2025-03-31) — End Cash Position: 5364434.00
ELAB cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2943185.00
ELAB cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1347416.00
ELAB cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 466678.00
ELAB cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 39676.00
ELAB cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -129613.00
ELAB income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 129613.00
ELAB income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -527468.00
ELAB balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -816.00
ELAB income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1023056.00
ELAB balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2072632.00
ELAB balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2604.00
ELAB income_statement (quarterly, 2025-03-31) — Gross Profit: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Interest Expense: 10474.00
ELAB income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 10474.00
ELAB income_statement (quarterly, 2025-03-31) — Interest Income: 28856.00
ELAB income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 28856.00
ELAB cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 789.00
ELAB balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8127875.00
ELAB cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -215319.00
ELAB balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 1484028.00
ELAB cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2604.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 1483849.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income: -1608455.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1608455.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1580811.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -27644.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1608455.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1580811.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1608455.00
ELAB income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1608455.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Net Interest Income: 18382.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -215319.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 18382.00
ELAB cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -479436.00
ELAB balance_sheet (quarterly, 2025-03-31) — Net PPE: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6055880.00
ELAB income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1170881.00
ELAB income_statement (quarterly, 2025-03-31) — Normalized Income: -1182956.00
ELAB cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1347416.00
ELAB cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 376741.00
ELAB income_statement (quarterly, 2025-03-31) — Operating Income: -1201338.00
ELAB income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 8417.00
ELAB balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -816.00
ELAB income_statement (quarterly, 2025-03-31) — Other Gand A: 1023056.00
ELAB income_statement (quarterly, 2025-03-31) — Other Income Expense: -397855.00
ELAB balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2072632.00
ELAB cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 23813.00
ELAB income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 109170.00
ELAB balance_sheet (quarterly, 2025-03-31) — Other Receivables: 52140.00
ELAB balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 557375.00
ELAB balance_sheet (quarterly, 2025-03-31) — Payables: 760268.00
ELAB balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 760268.00
ELAB balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 637.00
ELAB balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 637.00
ELAB balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 842199.00
ELAB income_statement (quarterly, 2025-03-31) — Pretax Income: -1580811.00
ELAB cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1938772.00
ELAB cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -430024.00
ELAB cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Receivables: 52140.00
ELAB income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1601.00
ELAB cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -179.00
ELAB income_statement (quarterly, 2025-03-31) — Research And Development: 32433.00
ELAB balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -14878082.00
ELAB cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 214705.00
ELAB income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 35594.00
ELAB income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1058650.00
ELAB balance_sheet (quarterly, 2025-03-31) — Share Issued: 8417.00
ELAB income_statement (quarterly, 2025-03-31) — Special Income Charges: 129613.00
ELAB cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: -58838.00
ELAB balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8128512.00
ELAB balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6055243.00
ELAB income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Total Assets: 8888780.00
ELAB balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8128512.00
ELAB balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8128512.00
ELAB income_statement (quarterly, 2025-03-31) — Total Expenses: 1201338.00
ELAB balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 760268.00
ELAB balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2072632.00
ELAB balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ELAB income_statement (quarterly, 2025-03-31) — Total Unusual Items: -397855.00
ELAB income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -397855.00
ELAB balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
ELAB balance_sheet (quarterly, 2025-03-31) — Trading Securities: 0.00
ELAB cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 60404.00
ELAB balance_sheet (quarterly, 2025-03-31) — Working Capital: 6055880.00
ELAB income_statement (quarterly, 2025-03-31) — Write Off: 0.00
ELAB income_statement (quarterly, 2025-06-30) — +Operating Expense: 1014401.00
ELAB income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 271567.00
ELAB balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 811.00
ELAB balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2604.00
ELAB balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 24490049.00
ELAB balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Basic Average Shares: 14806.00
ELAB income_statement (quarterly, 2025-06-30) — Basic EPS: -37.97
ELAB cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5364434.00
ELAB balance_sheet (quarterly, 2025-06-30) — Capital Stock: 785.00
ELAB balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 5682628.00
ELAB balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6307466.00
ELAB balance_sheet (quarterly, 2025-06-30) — Cash Financial: 5682628.00
ELAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1467583.00
ELAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 196840.00
ELAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1346298.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -428929.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Inventory: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Payable: -428929.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -428929.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 51424.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Receivables: -27813.00
ELAB cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -405318.00
ELAB cash_flow (quarterly, 2025-06-30) — Changes In Cash: 318125.00
ELAB balance_sheet (quarterly, 2025-06-30) — Common Stock: 148.00
ELAB balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 9048538.00
ELAB cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1519437.00
ELAB cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Current Assets: 7302844.00
ELAB balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 326301.00
ELAB cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 21.00
ELAB income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 20.00
ELAB cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 21.00
ELAB income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 20.00
ELAB income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 14806.00
ELAB income_statement (quarterly, 2025-06-30) — Diluted EPS: -37.97
ELAB income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -562355.00
ELAB balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 54734.00
ELAB income_statement (quarterly, 2025-06-30) — EBIT: -579488.00
ELAB income_statement (quarterly, 2025-06-30) — EBITDA: -579467.00
ELAB cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 69.00
ELAB cash_flow (quarterly, 2025-06-30) — End Cash Position: 5682628.00
ELAB cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1467583.00
ELAB cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1352298.00
ELAB cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -95184.00
ELAB cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 398386.00
ELAB balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1222.00
ELAB income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 802359.00
ELAB balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2072632.00
ELAB balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2604.00
ELAB cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Interest Expense: 2.00
ELAB income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2.00
ELAB income_statement (quarterly, 2025-06-30) — Interest Income: 36527.00
ELAB income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 36527.00
ELAB cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 2.00
ELAB balance_sheet (quarterly, 2025-06-30) — Invested Capital: 9048538.00
ELAB cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 196840.00
ELAB balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1519437.00
ELAB balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2604.00
ELAB cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1519437.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income: -562355.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -562355.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -579490.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 17135.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -562355.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -579490.00
ELAB cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -562355.00
ELAB income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -562355.00
ELAB cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -6000.00
ELAB income_statement (quarterly, 2025-06-30) — Net Interest Income: 36525.00
ELAB cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 330140.00
ELAB income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 36525.00
ELAB cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -51854.00
ELAB balance_sheet (quarterly, 2025-06-30) — Net PPE: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6976543.00
ELAB income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -977853.00
ELAB income_statement (quarterly, 2025-06-30) — Normalized Income: -977876.00
ELAB balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 127300.00
ELAB cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1346298.00
ELAB cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -95184.00
ELAB income_statement (quarterly, 2025-06-30) — Operating Income: -1014401.00
ELAB income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 17589.00
ELAB balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1222.00
ELAB income_statement (quarterly, 2025-06-30) — Other Gand A: 802359.00
ELAB income_statement (quarterly, 2025-06-30) — Other Income Expense: 398386.00
ELAB balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2072632.00
ELAB cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1.00
ELAB income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 63018.00
ELAB balance_sheet (quarterly, 2025-06-30) — Other Receivables: 76212.00
ELAB balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 624838.00
ELAB balance_sheet (quarterly, 2025-06-30) — Payables: 326301.00
ELAB balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 326301.00
ELAB balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 637.00
ELAB balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 637.00
ELAB balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 791055.00
ELAB income_statement (quarterly, 2025-06-30) — Pretax Income: -579490.00
ELAB cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -6000.00
ELAB cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -565076.00
ELAB balance_sheet (quarterly, 2025-06-30) — Receivables: 204323.00
ELAB income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 21.00
ELAB cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Research And Development: 66675.00
ELAB balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -15440437.00
ELAB cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 895216.00
ELAB income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 82329.00
ELAB income_statement (quarterly, 2025-06-30) — Selling General And Administration: 884688.00
ELAB balance_sheet (quarterly, 2025-06-30) — Share Issued: 17589.00
ELAB income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 15842.00
ELAB balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 9049175.00
ELAB balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6975906.00
ELAB income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Total Assets: 9375476.00
ELAB balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 9049175.00
ELAB balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 9049175.00
ELAB income_statement (quarterly, 2025-06-30) — Total Expenses: 1014401.00
ELAB balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 326301.00
ELAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2072632.00
ELAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ELAB income_statement (quarterly, 2025-06-30) — Total Unusual Items: 398386.00
ELAB income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 398386.00
ELAB balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Trading Securities: 0.00
ELAB balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 0.00
ELAB cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -299303.00
ELAB balance_sheet (quarterly, 2025-06-30) — Working Capital: 6976543.00
ELAB income_statement (quarterly, 2025-09-30) — +Operating Expense: 2272757.00
ELAB income_statement (quarterly, 2025-09-30) — +Total Revenue: 285948.00
ELAB balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 553879.00
ELAB balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 271492.00
ELAB balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -21812.00
ELAB balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 26525454.00
ELAB balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Basic Average Shares: 22019.00
ELAB income_statement (quarterly, 2025-09-30) — Basic EPS: -117.82
ELAB cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 5682628.00
ELAB cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -95594.00
ELAB balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1214900.00
ELAB balance_sheet (quarterly, 2025-09-30) — Capital Stock: 711.00
ELAB balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7700562.00
ELAB balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8504632.00
ELAB balance_sheet (quarterly, 2025-09-30) — Cash Financial: 7700562.00
ELAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 5705971.00
ELAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2198033.00
ELAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1490167.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 434809.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Inventory: 101531.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Payable: 434809.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 434809.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 73883.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Receivables: 22662.00
ELAB cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 632885.00
ELAB cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2017771.00
ELAB balance_sheet (quarterly, 2025-09-30) — Common Stock: 74.00
ELAB balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 8490018.00
ELAB cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: -86055.00
ELAB cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 207918.00
ELAB balance_sheet (quarterly, 2025-09-30) — Current Assets: 9772631.00
ELAB balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 229229.00
ELAB balance_sheet (quarterly, 2025-09-30) — Current Debt: 3194053.00
ELAB balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3423282.00
ELAB balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5461692.00
ELAB cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 35284.00
ELAB income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 35284.00
ELAB cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 35284.00
ELAB income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 35284.00
ELAB income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 22019.00
ELAB income_statement (quarterly, 2025-09-30) — Diluted EPS: -117.82
ELAB income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2594320.00
ELAB balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 486848.00
ELAB income_statement (quarterly, 2025-09-30) — EBIT: -2598617.00
ELAB income_statement (quarterly, 2025-09-30) — EBITDA: -2563333.00
ELAB cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 163.00
ELAB cash_flow (quarterly, 2025-09-30) — End Cash Position: 7700562.00
ELAB cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 5705971.00
ELAB balance_sheet (quarterly, 2025-09-30) — Finished Goods: 128469.00
ELAB cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1585761.00
ELAB cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 25871.00
ELAB cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -254731.00
ELAB balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -753.00
ELAB income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1736757.00
ELAB balance_sheet (quarterly, 2025-09-30) — Goodwill: 959535.00
ELAB balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3508199.00
ELAB balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1679000.00
ELAB income_statement (quarterly, 2025-09-30) — Gross Profit: 78030.00
ELAB cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Interest Expense: 17401.00
ELAB income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 17401.00
ELAB income_statement (quarterly, 2025-09-30) — Interest Income: 24406.00
ELAB income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 24406.00
ELAB cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 13598.00
ELAB balance_sheet (quarterly, 2025-09-30) — Inventory: 128469.00
ELAB balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11684071.00
ELAB cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2198033.00
ELAB balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 0.00
ELAB balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: -86055.00
ELAB balance_sheet (quarterly, 2025-09-30) — Leases: 35420.00
ELAB balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 985671.00
ELAB balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 985671.00
ELAB balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 399838.00
ELAB cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -86055.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income: -2594320.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2594320.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2616018.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 21698.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2594320.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2616018.00
ELAB cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2594320.00
ELAB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2594320.00
ELAB cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Net Interest Income: -172474.00
ELAB cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -432652.00
ELAB income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -172474.00
ELAB cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 4521297.00
ELAB cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
ELAB balance_sheet (quarterly, 2025-09-30) — Net PPE: 1657188.00
ELAB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4982456.00
ELAB income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2308602.00
ELAB income_statement (quarterly, 2025-09-30) — Normalized Income: -2361287.00
ELAB cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1490167.00
ELAB cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 25871.00
ELAB income_statement (quarterly, 2025-09-30) — Operating Income: -2194727.00
ELAB income_statement (quarterly, 2025-09-30) — Operating Revenue: 285948.00
ELAB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 31004.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 3194053.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 681818.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -753.00
ELAB income_statement (quarterly, 2025-09-30) — Other Gand A: 1736757.00
ELAB income_statement (quarterly, 2025-09-30) — Other Income Expense: -248817.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2548664.00
ELAB cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 166473.00
ELAB income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 5914.00
ELAB income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 421232.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Payable: 315865.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Properties: 1243742.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Receivables: 97940.00
ELAB balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 804070.00
ELAB balance_sheet (quarterly, 2025-09-30) — Payables: 1356592.00
ELAB balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1356592.00
ELAB balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 637.00
ELAB balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 637.00
ELAB balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 770098.00
ELAB income_statement (quarterly, 2025-09-30) — Pretax Income: -2616018.00
ELAB cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1270729.00
ELAB balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -568959.00
ELAB balance_sheet (quarterly, 2025-09-30) — Receivables: 369432.00
ELAB income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 207918.00
ELAB income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 35284.00
ELAB cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Research And Development: 15000.00
ELAB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -18034757.00
ELAB cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 136307.00
ELAB income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 64484.00
ELAB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1801241.00
ELAB balance_sheet (quarterly, 2025-09-30) — Share Issued: 31004.00
ELAB income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 13179.00
ELAB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 8490655.00
ELAB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4981819.00
ELAB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ELAB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Assets: 14938018.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8490655.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Debt: 4408953.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8490655.00
ELAB income_statement (quarterly, 2025-09-30) — Total Expenses: 2480675.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 6447363.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5165387.00
ELAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 985671.00
ELAB income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 179479.00
ELAB income_statement (quarterly, 2025-09-30) — Total Unusual Items: -254731.00
ELAB income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -254731.00
ELAB balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 0.00
ELAB balance_sheet (quarterly, 2025-09-30) — Trading Securities: 0.00
ELAB balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 0.00
ELAB cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 230461.00
ELAB balance_sheet (quarterly, 2025-09-30) — Working Capital: 4310939.00
ELAB income_statement (annual, 2025-12-31) — +Operating Expense: 7006644.00
ELAB income_statement (quarterly, 2025-12-31) — +Operating Expense: 2518148.00
ELAB income_statement (annual, 2025-12-31) — +Total Revenue: 590084.00
ELAB income_statement (quarterly, 2025-12-31) — +Total Revenue: 304136.00
ELAB balance_sheet (annual, 2025-12-31) — Accounts Payable: 697633.00
ELAB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 697633.00
ELAB balance_sheet (annual, 2025-12-31) — Accounts Receivable: 245423.00
ELAB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 245423.00
ELAB balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -53532.00
ELAB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -53532.00
ELAB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 28856496.00
ELAB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 28856496.00
ELAB cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 500000.00
ELAB balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
ELAB balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
ELAB income_statement (annual, 2025-12-31) — Basic Average Shares: 20335.00
ELAB income_statement (annual, 2025-12-31) — Basic EPS: -380.99
ELAB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3984453.00
ELAB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 7700562.00
ELAB cash_flow (annual, 2025-12-31) — Capital Expenditure: -448255.00
ELAB cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -346661.00
ELAB balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1220470.00
ELAB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1220470.00
ELAB balance_sheet (annual, 2025-12-31) — Capital Stock: 645.00
ELAB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 645.00
ELAB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5402333.00
ELAB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5402333.00
ELAB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5974387.00
ELAB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5974387.00
ELAB balance_sheet (annual, 2025-12-31) — Cash Financial: 5402333.00
ELAB balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5402333.00
ELAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 10116738.00
ELAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1.00
ELAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2765154.00
ELAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -548642.00
ELAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5933881.00
ELAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1750000.00
ELAB cash_flow (annual, 2025-12-31) — Change In Account Payable: 957759.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 692218.00
ELAB cash_flow (annual, 2025-12-31) — Change In Inventory: 147868.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Inventory: 23371.00
ELAB cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -20496.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 0.00
ELAB cash_flow (annual, 2025-12-31) — Change In Payable: 560031.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Payable: 692218.00
ELAB cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 560031.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 692218.00
ELAB cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1311.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -193571.00
ELAB cash_flow (annual, 2025-12-31) — Change In Receivables: -100594.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Receivables: -18783.00
ELAB cash_flow (annual, 2025-12-31) — Change In Working Capital: 588120.00
ELAB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 503235.00
ELAB cash_flow (annual, 2025-12-31) — Changes In Cash: 1417703.00
ELAB cash_flow (quarterly, 2025-12-31) — Changes In Cash: -2298643.00
ELAB balance_sheet (annual, 2025-12-31) — Common Stock: 8.00
ELAB balance_sheet (quarterly, 2025-12-31) — Common Stock: 8.00
ELAB balance_sheet (annual, 2025-12-31) — Common Stock Equity: 7836725.00
ELAB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 7836725.00
ELAB cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2917409.00
ELAB cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -1.00
ELAB cash_flow (annual, 2025-12-31) — Common Stock Payments: -179.00
ELAB cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
ELAB income_statement (annual, 2025-12-31) — Cost Of Revenue: 404770.00
ELAB income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 196852.00
ELAB balance_sheet (annual, 2025-12-31) — Current Assets: 6871255.00
ELAB balance_sheet (quarterly, 2025-12-31) — Current Assets: 6871255.00
ELAB balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 247627.00
ELAB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 247627.00
ELAB balance_sheet (annual, 2025-12-31) — Current Debt: 1339479.00
ELAB balance_sheet (quarterly, 2025-12-31) — Current Debt: 1339479.00
ELAB balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1587106.00
ELAB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1587106.00
ELAB balance_sheet (annual, 2025-12-31) — Current Liabilities: 3942296.00
ELAB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3942296.00
ELAB cash_flow (annual, 2025-12-31) — Deferred Income Tax: 30972.00
ELAB cash_flow (annual, 2025-12-31) — Deferred Tax: 30972.00
ELAB cash_flow (annual, 2025-12-31) — Depreciation: 96663.00
ELAB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 96663.00
ELAB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 59757.00
ELAB income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 96145.00
ELAB income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 59756.00
ELAB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 96663.00
ELAB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 59757.00
ELAB income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 96145.00
ELAB income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 59756.00
ELAB income_statement (annual, 2025-12-31) — Diluted Average Shares: 20335.00
ELAB income_statement (annual, 2025-12-31) — Diluted EPS: -380.99
ELAB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -7747813.00
ELAB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2982683.00
ELAB balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 1032895.00
ELAB balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 1032895.00
ELAB income_statement (annual, 2025-12-31) — EBIT: -7492138.00
ELAB income_statement (quarterly, 2025-12-31) — EBIT: -2743696.00
ELAB income_statement (annual, 2025-12-31) — EBITDA: -7395475.00
ELAB income_statement (quarterly, 2025-12-31) — EBITDA: -2683939.00
ELAB cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 177.00